Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Woodland Rd
Saint Helena, CA 94574Phone+1 707-967-5721
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2005 - 2008
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2001 - 2004
Keck School of Medicine of the University of Southern CaliforniaClass of 2001
Certifications & Licensure
CA State Medical License 2002 - 2026
OH State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 58 citationsIrinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety.Tyler Y. Kang, Tony Jin, Heinrich Elinzano, David M. Peereboom
Journal of Neuro-Oncology. 2008-04-26 - 6 citationsFunctional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response.Tyler Y. Kang, Peter W. Nichols, Eila C. Skinner, Susan Groshen, Greg Valin
BJU International. 2007-05-01 - 11 citationsThalidomide use and digital gangrene.Tyler Y. Kang, Christopher Lowe, Mikkael A. Sekeres
Journal of Clinical Oncology. 2006-11-20
Committees
- Chair, Cancer committee 2020 - Present
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
